SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-18-060759
Filing Date
2018-10-05
Accepted
2018-10-09 08:34:53
Documents
8
Period of Report
2018-10-30
Effectiveness Date
2018-10-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A a18-31159_1def14a.htm DEF 14A 222254
2 GRAPHIC g311591bci001.jpg GRAPHIC 3804
3 GRAPHIC g311591bci002.gif GRAPHIC 2809
4 GRAPHIC g311591bei001.jpg GRAPHIC 3804
5 GRAPHIC g311591bqi001.gif GRAPHIC 110404
6 GRAPHIC g311591bqi002.gif GRAPHIC 89148
7 GRAPHIC g311591bgi001.gif GRAPHIC 2496
8 GRAPHIC g311591boi001.gif GRAPHIC 3795
  Complete submission text file 0001104659-18-060759.txt   522149
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 0131
Type: DEF 14A | Act: 34 | File No.: 001-33818 | Film No.: 181112286
SIC: 3845 Electromedical & Electrotherapeutic Apparatus